Detalhe da pesquisa
1.
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors.
Cancer
; 125(16): 2837-2845, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012962
2.
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Br J Cancer
; 116(11): 1402-1407, 2017 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28441383
3.
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.
J Transl Med
; 13: 214, 2015 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26143264
4.
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Br J Cancer
; 118(2): e2, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315294